33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15823)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7078)
  4. Hematologic Malignancies, Division of (6211)
  5. Center for Hematologic Malignancies (6018)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4873)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15823)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7078)
  4. Hematologic Malignancies, Division of (6211)
  5. Center for Hematologic Malignancies (6018)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Study EV-103: New cohorts testing enfortumab vedotin alone or in combination with pembrolizumab in muscle invasive urothelial cancer
    Meeting Abstract

    Hoimes, C. J.; Rosenberg, J. E.; Petrylak, D. P.; Carret, A. S.; Sasse, C.; Chaney, M. F.; Flaig, T. W.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Response to systemic therapy in patients with metastatic fumarate hydratase (FH) deficient renal cell carcinoma (RCC)
    Meeting Abstract

    Gleeson, J. P.; Nikolovski, I.; Kotecha, R.; Ged, Y.; Shapnik, N.; Knezevic, A.; Feldman, D. R.; Lee, C. H.; Voss, M. H.; Chen, Y. B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Treatment timing in localized high-risk prostate cancer treated with radiation and androgen deprivation therapy
    Meeting Abstract

    Hasan, S.; Lazarev, S.; Gorovets, D.; Garg, M.; Press, R. H.; Choi, I.; Simone, C. B.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Causes and patterns of mortality in patients with lethal germ cell tumor (GCT)
    Meeting Abstract

    Hamid, A.; Funt, S. A.; Markt, S. C.; Bromberg, M.; O'Donnell, D.; Adra, N.; Taza, F.; Albany, C.; Krailo, M. D.; Frazier, A. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Adverse event profiles of apalutamide, enzalutamide, and darolutamide in SPARTAN, PROSPER, and ARAMIS: How confident are we about which drug is safest?
    Meeting Abstract

    Drago, J. Z.; Kantoff, P. W.; Stopsack, K. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genetic risk assessment for hereditary RCC: Report from the consensus panel meeting
    Meeting Abstract

    Daneshvar, M.; Mendhiratta, N.; Srinivasan, R.; Jonasch, E.; Ball, M. W.; Metwali, A. R.; Brugarolas, J.; Singer, E. A.; Nathanson, K.; Pierorazio, P. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Differential expression of melanoma-associated antigen A3/6 and associated immune molecules prior to and post treatment with immune checkpoint inhibitors (ICI) in patients with mUC
    Meeting Abstract

    Faiena, I.; Funt, S. A.; Astrow, S. H.; Dorff, T. B.; Adhikary, S.; Gorgan, T.; Rosenberg, J. E.; Elashoff, D.; Pantuck, A. J.; Drakaki, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Detailed evaluation of hearing loss (HL) associated with high-dose (HD) carboplatin for salvage treatment of germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Knezevic, A.; Wilson, K.; Bromberg, M.; Budnick, A.; McHugh, D. J.; Larsen, E.; Bajorin, D. F.; Motzer, R. J.; Tonorezos, E. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic determinants of nested variant urothelial carcinoma
    Meeting Abstract

    Clinton, T. N.; Whiting, K.; Silva, V.; Li, Q.; Almassi, N.; Pietzak, E.; Bagrodia, A.; Cha, E. K.; Dalbagni, G.; Iyer, G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Defining the genetic evolution of epigenetic alterations in bladder cancer
    Meeting Abstract

    Clinton, T. N.; Wise, H.; Almassi, N.; Chavan, S. S.; Hu, W.; Gao, S. P.; Hanrahan, A.; Dason, S.; Pietzak, E. J.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save